DNA-binding activity and biological effects of aromatic polyamidines

Biochemical Pharmacology

Volumn 47, Issue 4, 1994, Pages 599-610

  Gambari, Roberto ^a   Nastruzzi, Claudio ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; AROMATIC POLYAMIDE; DIMINAZENE ACETURATE; DISTAMYCIN A; PENTAMIDINE; POLYAMIDINE; PROPAMIDINE; STILBAMIDINE; UNCLASSIFIED DRUG;

CANCER; DNA BINDING; DRUG ACTIVITY; DRUG DESIGN; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INFECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; REGULATORY MECHANISM;

AMIDINES; ANIMAL; ANTI-INFECTIVE AGENTS; BASE SEQUENCE; DNA; GENE EXPRESSION REGULATION; HUMAN; MOLECULAR SEQUENCE DATA; PENTAMIDINE; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0028211441     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(94)90121-X     Document Type: Article

References (121)

1. Selection of DNA binding sites by regulatory proteins
2. Purification and biochemical characterization of the promoter specific transcription factor Sp1
3. Promoter specificity and modulation of RNA polymerase II transcription
4. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: Cloning and expression of multiple cDNAs
5. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins
6. HIV-1 structural gene expression requires the binding of multiple REV monomers to the viral RRE: Implication for HIV-1 latency
7. DNA structure and perturbation by drug binding
8. Molecular recognition of B-DNA by Hoechst 33258
9. Molecular recognition between oligopeptides and nucleic acids. Monocationic imidazole lexitropsins that display enhanced GC sequence dependent DNA binding
10. Structure-activity relationship of novel oligopeptide antiviral and antitumour agents related to netropsin and distamycin
11. Lexitropsins: Rationale design of DNA sequence reading agents as novel anticancer agents and potential cellular probes
12. Existence of an extended series of antitumor compounds which bind to deoxyribonucleic acid by nonintercalative means
13. Design of sequence-specific DNA binding molecules
14. Alteration of the sequence specificity of distamycin on DNA by replacement of an N-methylpyrrolecarboxamide with pyridine-2-carboxamide
15. The location of cis-acting regulatory sequences in human T-cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat
16. Location of the trance-activating region of the genome of the human T-cell lymphotropic virus type III
17. HIV enhancer activity perpetuated by NF-kB induction on infection of monocytes
18. Pathways of viral infections. Basic concepts derived from the retrovirus model. N
19. Trypanocide Diamidine mit vier Ringen in einem oder zwei Ringsystemen
20. Trypanocide Diamidine mit drei isolierten Ringsystemen
21. Synthesen biskationischer, trypanocider 1-Benzofuran-Verbindungen
22. Synthesen antimikrobieller biskationischer 2-(Phenoxyphenyl)-indole und -1-benzofurane
23. Synthese antileukämischer Indolylvinyl-1-benzofurane und-benzo[b]thiophene
24. Synthesen antileukämischer (Indolylvinyl)indole
25. Hydroxystilbamidine. A nonintercalating drug as a probe of nucleic acid conformation
26. Crystal structure of a berenil-dodecanucleotide complex: The role of water in sequence-specific ligand binding
27. 2
28. 2 in solution studied by NMR
29. Diaryl amidine derivatives as oncornaviral DNA polymerase inhibitors
30. Analogous of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia
31. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis
32. Structure and DNA binding activity of analogs of l,5-bis(4-amidinophenoxy)pentane (pentamidine)
33. Crystal structure and molecular modelling of the antimicrobial drug pentamidine
34. Differential effects of benzamidine derivatives on the expression of c-myc and HLA-DRα genes in a human B-lymphoid tumor cell line
35. Inhibition of in vitro tumour cell growth by aromatic polyamidines exhibiting antiproteinase activity
36. Binding of 4',6-diamidino-2-phenylindole (DAPI) to GC and mixed sequences in DNA: Intercalation of a classical grove-binding molecule
37. Friend erythroleukemic cells treated with aromatic poly-amidines exhibiting antiproteinase activity: Inhibition of cell growth is not associated with block of induced erythroid differentiation
38. Aromatic tetra-amidines: Synthesis of halo-derivatives and their antiproteolytic activity
39. Aromatic polyamidines: Inhibitory effect on purified plasma serine proteinases, blood coagulation and platelet aggregation
40. Effects of the proteinase inhibitor tetra-p-amidinophenoxyneopentane on in vitro adhesion and invasiveness of tumor cells
41. Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats
42. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome
43. Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia
44. Treatment and prophylaxis of Pneumocystis carinii pneumonia in AIDS patient
45. Efficacy and effects on pulmonary function tests of weekly 600 mg aerosol pentamidine as prophylaxis against Pneumocystis carinii pneumonia
46. Successful Intermittent Chemoprophylaxis forPneumocystis cariniiPneumonitis
47. DNA-binding activity and inhibition of DNA-protein interaction
48. Tetra-amidines exhibiting anti-proteinase activity: Effects on oriented migration and in vitro invasiveness of a Chinese hamster cell line transfected with the activated human T24-Ha-ras-1 oncogene
49. Antitumor activity of the proteinase inhibitor tetra-p-amidino phenoxy-neopentane in a nude mouse model of human melanoma
50. Malignant transformation of early passage rodent cells by a single mutated human oncogene
51. Molecular evolution of the Ha-ras-1 oncogene: Relationship between DNA methylation, frequency of CpG dinucleotides and binding to the Sp1 transacting factor
52. Tumor cell growth inhibition by liposome-encapsulated aromatic polyamidines
53. Preparation of pullulan based microspheres: Entrapment of aromatic tetra-amidines by ion-exchange principles
54. Comparison of nebulizer efficiency for aerosolizing pentamidine
55. Selective enhancement of pentamidine uptake in the lungs by aerosolization and delivery in liposomes
56. Diamidino-.alpha.,.omega.-diphenoxyalkanes. Structure-activity relations for the inhibition of thrombin, pancreatic kallikrein, and trypsin
57. New aromatic diamidines with central α-oxyalkane or α,ω-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation process
58. Tetra-p-amidinophenoxypropane as a probe of the specificity site of serine proteases
59. Inhibition of bovine β-trypsin, human α-thrombin and porcine pancreaticβ-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: Thermodynamic and molecular modeling study
60. TAPP (tetra-p-amidinophenoxyneopentane) inhibits the binding of nuclear factors to target DNA sequences
61. Molecular structure of the netropsin-d(CGCGATATCGCG) complex: DNA conformation in an alternating AT segment
62. Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: Evidence for molecular models involving intercalation
63. Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DRα-gene
64. Hydroxy radical footprinting of the sequence-selective binding of netropsin and distamycin to DNA
65. Minor-groove width and accessibility in B-DNA drug and protein complexes
66. Assignment of DNA binding sites for 4'-6-diamidine-2-henylindole and bisbenzimide (Hoechst 33258). A comparative study
67. The molecular origin of DNA-drug specificity in netropsin and distamycin
68. Synthesis, DNA binding properties and antitumour activity of novel distamycin derivatives
69. 1H NMR studies on the interaction between distamycin A and a symmetrical DNA dodecamer
70. Comparison of binding sites in DNA for berenil, netropsin and distamycin: A footprinting study
71. Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agents
72. Footprinting studies on the sequence-selective binding of pentamidine to DNA
73. Crystal structure of a pentamidine-oligonucleotide complex: Implication for DNA-binding properties
74. Compilation of vertebrate-encoded transcription factors
75. Transcriptional control signals in the genome of bovine papillomavirus type 1
76. A region of the polyoma virus genome between the replication origin and late protein coding sequences is required in cis for both early gene expression and viral DNA replication
77. The POU domain: A large conserved region in the mammalian pit-1, oct-1, oct-2 and Caenorhabditis elegans unc-86 gene products
78. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain
79. Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene
80. Oncogenic conversion by regulatory changes in transcription factors
81. The “initiator” as a transcriptional control element
82. Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site
83. Transcription by RNA polymerase II: Initiator-directed formation of transcription-competent complexes
84. Mechanism of transcriptional activation by Spl: Evidence for coactivators
85. Genetic complexity and expression of human class II histocompatibility antigens
86. Gel electrophoresis assays for DNA-protein interactions
87. Gel electrophoresis of protein-DNA complexes
88. The use of gel electrophoresis to detect and study nucleic acid— protein interactions
89. The use of micrococcal nuclease as a probe for drug binding sites on DNA
90. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
91. Equilibria and kinetics of lac represser-operator interactions by polyacrylamide gel electrophoresis
92. Gel retardation at low pH resolves trp repressor-DNA complexes for quantitative study
93. Human HLA-DRα-gene: A rare oligonucleotide (GTATA) identifies an upstream sequence required for nuclear protein binding
94. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells
95. A simple quantitative assay for chloramphenicol acetyltransferase by direct extraction of the labeled product into scintillation cocktail
96. In vitro transcription analysis of the role of DNA flanking sequences on adriamycin sequence selectivity
97. Bidirectional transcription footprinting
98. A human retinoic acid receptor which belongs to the family of nuclear receptors
99. Analysis of DNA restriction fragments and polymerase chain reaction products toward detection of the AIDS (HIV-1) virus in blood
100. The polymerase chain reaction for the detection of HIV-1 genomic RNA in plasma from infected individuals
101. DNA-binding activity of the proteinase inhibitor TAPP
102. Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements
103. Distamycin-induced inhibition of homeodomain-DNA complexes
104. Specific inhibition of human DNA ligase adenylation by a distamycin derivative possessing antitumor activity
105. The mouse albumin enhancer contains a negative regulatory element that interacts with a novel DNA-binding protein
106. Molecular cloning and characterization of a human DNA binding factor that represses transcription
107. A transcriptional represser of c-myc
108. Expression of rafoncogenes activates the PEA1 transcription factor motif
109. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity
110. Convulsant-induced increase in transcription factor messenger RNAs in rat brain
111. Transcription inhibition of the somatic-type phosphoglycerate kinase 1 gene in vitro by a testis-specific factor that recognizes a sequence similar to the binding site for Ets oncoproteins
112. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
113. Nef protein of HIV-1 is a transcriptional represser of HIV-1 LTR
114. Cisplatin stimulates the expression from the human immunodeficiency virus long terminal repeat sequences in human fibroblasts
115. Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element
116. The search for structure specific nucleic acid interactive drugs: Effects of structure on RNA versus DNA interaction strength
117. 1-Substituted benzamidines: Synthesis, antiproteinase activity and inhibition of tumor cell growth
118. 1-Substituted tetra-benzamidines: Inhibition of DNA-protein interactions and in vitro tumor cell growth